Denali Therapeutics Inc. (DNLI)

Smartsheet Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	56.95	174.96	127.11	218.04	293.48	507.14
Short-Term Investments	760.98	657.37	907.41	1,118	571.93	962.55
Cash & Short-Term Investments	817.93	832.33	1,035	1,336	865.41	1,470
Cash Growth	-12.70%	-19.54%	-22.58%	54.40%	-41.12%	253.84%
Accounts Receivable	-	2.17	3.42	9.28	-	-
Other Receivables	1.7	-	-	-	1.23	5.67
Receivables	1.7	2.17	3.42	9.28	1.23	5.67
Prepaid Expenses	59.01	29.93	26.21	26.82	30.6	20.28
Total Current Assets	878.64	864.44	1,064	1,372	897.23	1,496
Property, Plant & Equipment	129.93	125.63	71.64	74.52	69.61	73.46
Long-Term Investments	235.84	374.37	-	-	425.45	32.7
Other Long-Term Assets	26.93	9.74	18.14	13.4	11.87	2.46
Total Assets	1,271	1,374	1,154	1,460	1,404	1,604
Accounts Payable	8.46	11.14	9.48	2.79	4.78	1.07
Accrued Expenses	54.56	64.91	61.24	59.37	47.71	42.46
Current Portion of Leases	11.52	12.03	7.26	7.32	5.45	4.69
Current Unearned Revenue	-	-	-	290.05	320.3	23.48
Other Current Liabilities	17.34	14.13	-	4.39	-	-
Total Current Liabilities	91.88	102.21	77.98	363.92	378.25	71.7
Long-Term Leases	40.05	42.29	44.98	53.03	58.55	64.18
Long-Term Unearned Revenue	-	-	-	0.48	4.69	317.17
Other Long-Term Liabilities	16.73	-	-	0.38	0.38	0.7
Total Liabilities	148.66	144.5	122.96	417.81	441.87	453.75
Common Stock	1.78	1.77	1.71	1.69	1.55	1.53
Additional Paid-In Capital	2,791	2,765	2,145	2,019	1,608	1,504
Retained Earnings	-1,672	-1,539	-1,116	-970.99	-645	-354.42
Comprehensive Income & Other	2.04	2.02	0.64	-6.89	-2.5	-0.25
Total Common Equity	1,123	1,230	1,031	1,042	962.29	1,151
Shareholders' Equity	1,123	1,230	1,031	1,042	962.29	1,151
Total Liabilities & Equity	1,271	1,374	1,154	1,460	1,404	1,604
Total Debt	51.57	54.32	52.24	60.35	64.01	68.87
Net Cash (Debt)	1,002	1,137	982.27	1,276	1,227	1,434
Net Cash Growth	-27.22%	15.79%	-23.01%	4.00%	-14.42%	274.57%
Net Cash Per Share	5.90	6.92	7.15	10.16	10.10	12.72
Filing Date Shares Outstanding	145.28	145.22	139.16	136.68	122.83	120.98
Total Common Shares Outstanding	145.25	144.22	138.39	135.97	122.28	120.53
Working Capital	786.76	762.23	986.16	1,008	518.99	1,424
Book Value Per Share	7.73	8.53	7.45	7.67	7.87	9.55
Tangible Book Value	1,123	1,230	1,031	1,042	962.29	1,151
Tangible Book Value Per Share	7.73	8.53	7.45	7.67	7.87	9.55
Machinery	-	60.37	50.35	37.6	32.97	26.91
Leasehold Improvements	-	46.91	41.24	43.7	35.24	34.74

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q